{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:40:11Z","timestamp":1792363211163,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"DOI":"10.1186\/s41824-026-00326-3","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:01:56Z","timestamp":1792360916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding role of nuclear medicine in cardiac amyloidosis: insights from the EJNMMI collection"],"prefix":"10.1186","volume":"10","author":[{"given":"Mahdi","family":"Zirakchian Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"M. Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"326_CR1","unstructured":"American Society of Nuclear Cardiology (ASNC) (2022. Available at: 99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis: aSNC practice points update. ASNC Practice Points PDF"},{"issue":"5","key":"326_CR2","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s00259-025-07718-w","volume":"53","author":"G Bonnans","year":"2026","unstructured":"Bonnans G, Blanc P, Cariou E, Engel R, Legallois D, Malerbi H, Cazalbou S, Lavie-Badie Y, Cassol E, Beaurain M, Fournier P, Manrique A, Lairez O, Alric L, Bureau C, Chauveau D, Cintas P, Colombat M, Dupin-Deguine D, Huart A, Puissant B, Pugnet G, Pr\u00e9vot G, Ribes D, Sailler L (2026) Aortic valve calcium score from computed tomography for signal localization by cardiac amyloid radionuclide imaging to predict aortic stenosis and assess prognosis in patients with transthyretin cardiomyopathy. Eur J Nucl Med Mol Imag 53(5):3351\u20133363. https:\/\/doi.org\/10.1007\/s00259-025-07718-w","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"326_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ajh.23400","volume":"88","author":"MA Gertz","year":"2013","unstructured":"Gertz MA (2013) Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol 88(5):416\u2013425. https:\/\/doi.org\/10.1002\/ajh.23400","journal-title":"Am J Hematol"},{"issue":"4","key":"326_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International symposium on amyloid and amyloidosis, tours, France, 18\u201322 April 2004. Am J Hematol 79(4):319\u2013328. https:\/\/doi.org\/10.1002\/ajh.20381","journal-title":"Am J Hematol"},{"issue":"2","key":"326_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","volume":"12","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Dispenzieri A, Sher T (2015 Feb) Pathophysiology and treatment of cardiac amyloidosis. Nat Rev Cardiol 12(2):91\u2013102. https:\/\/doi.org\/10.1038\/nrcardio.2014.165. Epub 2014 Oct 14. PMID: 25311231","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"326_CR6","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00259-024-06727-5","volume":"51","author":"I Gotuzzo","year":"2024","unstructured":"Gotuzzo I, Slart RHJA, Gimelli A, Ashri N, Anagnostopoulos C, Bucerius J, Buechel RR, Gaemperli O, Gheysens O, Glaudemans AWJM, Habib G, Hyafil F, Lubberink M, Saraste A, Podlesnikar T, Dweck MR, Erba PA (2024 Jun) Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis. A survey endorsed by the EANM and EACVI. Eur J Nucl Med Mol Imag 51(7):1809\u20131815. https:\/\/doi.org\/10.1007\/s00259-024-06727-5. PMID: 38679624","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"326_CR7","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1007\/s00259-024-06966-6","volume":"52","author":"K Holcman","year":"2025","unstructured":"Holcman K, Rubi\u015b P, \u0106miel B, St\u0119pie\u0144 A, Graczyk K, Mr\u00f3z K, Szot W, Dziewi\u0119cka E, Winiarczyk M, Kurek M, K\u0119ska M, Podolec P, Kostkiewicz M (2025) Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis. Eur J Nucl Med Mol Imag 52(5):1840\u20131852. https:\/\/doi.org\/10.1007\/s00259-024-06966-6","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"9","key":"326_CR8","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s00259-025-07157-7","volume":"52","author":"Z Hong","year":"2025","unstructured":"Hong Z, Spielvogel CP, Xue S, Calabretta R, Jiang Z, Yu J, Kluge K, Haberl D, Nitsche C, Gr\u00fcnert S, Hacker M, Li X (2025) Enhanced diagnostic and prognostic assessment of cardiac amyloidosis using combined 11C-PiB PET\/CT and 99mTc-DPD scintigraphy. Eur J Nucl Med Mol Imag 52(9):3321\u20133332. https:\/\/doi.org\/10.1007\/s00259-025-07157-7","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"13","key":"326_CR9","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1007\/s00259-025-07308-w","volume":"52","author":"Z Hong","year":"2025","unstructured":"Hong Z, Xue S, Yu J, Calabretta R, Haberl D, Jiang Z, Gr\u00fcnert S, Beitzke D, Kammerlander A, Hacker M, Li X (2025) Total-body 11C-PIB PET\/CT imaging of systemic amyloidosis: inter-organ connectivity in cardiac amyloidosis for prognostic insights. Eur J Nucl Med Mol Imag 52(13):4985\u20134999. https:\/\/doi.org\/10.1007\/s00259-025-07308-w","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"326_CR10","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1007\/s00259-025-07719-9","volume":"53","author":"Y Li","year":"2026","unstructured":"Li Y, Pan M, Yu H, Zhang Q, Chang Y, Zhao H, Wang J, Wang X, Dai J, Yu L, Chen D, Zhang J, Yan X-X, Yao S, Cui M (2026) Preclinical and preliminary clinical evaluation of [18F]Florbetazine for non-invasive PET detection of cardiac amyloidosis. Eur J Nucl Med Mol Imag 53(5):3364\u20133374. https:\/\/doi.org\/10.1007\/s00259-025-07719-9","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"326_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MD.0b013e31821cbdab","volume":"90","author":"M Monge","year":"2011","unstructured":"Monge M, Chauveau D, Cordonnier C, No\u00ebl L-H, Presne C, Makdassi R, Jaur\u00e9guy M, Lecaque C, Renou M, Gr\u00fcnfeld J-P, Choukroun G (2011) Localized amyloidosis of the genitourinary tract: report of 5 new cases and review of the literature. Med (Baltim) 90(3):212\u2013222. https:\/\/doi.org\/10.1097\/MD.0b013e31821cbdab","journal-title":"Med (Baltim)"},{"issue":"2","key":"326_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00259-024-06928-y","volume":"52","author":"SA Muller","year":"2025","unstructured":"Muller SA, Hauptmann L, Nitsche C, Oerlemans MI (2025 Jan) Utilizing artificial intelligence to detect cardiac amyloidosis in patients with severe aortic stenosis: a step forward to diagnose the underdiagnosed. Eur J Nucl Med Mol Imag 52(2):482\u2013484. https:\/\/doi.org\/10.1007\/s00259-024-06928-y. PMID: 39331132","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"326_CR13","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1007\/s00259-025-07653-w","volume":"53","author":"M Poledniczek","year":"2026","unstructured":"Poledniczek M, Rettl R, Kronberger C, Schmid LM, Ermolaev N, Duca F, Nitsche C, Binder C, Camuz Ligios L, Eslami M, Binder P, Spielvogel CP, Badr Eslam R, Beitzke D, Kastner J, Bergler-Klein J, Kammerlander AA, Hengstenberg C, Hacker M, Calabretta R (2026) Additive diagnostic value of thoracic SPECT\/CT imaging in perugini grade 1 patients who underwent bone scintigraphy. Eur J Nucl Med Mol Imag 53(4):2662\u20132673. https:\/\/doi.org\/10.1007\/s00259-025-07653-w","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"7","key":"326_CR14","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00259-025-07117-1","volume":"52","author":"Y Salimi","year":"2025","unstructured":"Salimi Y, Shiri I, Mansouri Z, Sanaat A, Hajianfar G, Hervier E, Bitarafan A, Caobelli F, Hundertmark M, Mainta I, Gr\u00e4ni C, Nkoulou R, Zaidi H (2025) Artificial intelligence-based cardiac transthyretin amyloidosis detection and scoring in scintigraphy imaging: multi-tracer, multi-scanner, and multi-center development and evaluation study. Eur J Nucl Med Mol Imag 52(7):2513\u20132528. https:\/\/doi.org\/10.1007\/s00259-025-07117-1","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"326_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00259-024-06922-4","volume":"52","author":"I Shiri","year":"2025","unstructured":"Shiri I, Balzer S, Baj G, Bernhard B, Hundertmark M, Bakula A, Nakase M, Tomii D, Barbati G, Dobner S, Valenzuela W, Rominger A, Caobelli F, Siontis GCM, Lanz J, Pilgrim T, Windecker S, Stortecky S, Gr\u00e4ni C (2025) Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis. Eur J Nucl Med Mol Imag 52(2):485\u2013500. https:\/\/doi.org\/10.1007\/s00259-024-06922-4","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"326_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1753465814524470","volume":"8","author":"P Sommer","year":"2014","unstructured":"Sommer P, Kumar G, Lipchik RJ, Patel JJ (2014) Tracheobronchial amyloidosis managed with multimodality therapies. Ther Adv Respir Dis 8(2):48\u201352. https:\/\/doi.org\/10.1177\/1753465814524470","journal-title":"Ther Adv Respir Dis"},{"key":"326_CR17","doi-asserted-by":"publisher","unstructured":"Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub-Weidinger T, Davies RH, Pierce I, Patel K, Nakuz T, G\u00f6llner A, Amereller D, Starace M, Monaci A, Weber M, Li X, Haug AR, Calabretta R, Ma X, Zhao M, Mascherbauer J, Kammerlander A, Hengstenberg C, Menezes LJ, Sciagra R, Treibel TA, Hacker M, Nitsche C (2024 Apr) Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study. Lancet Digit Health 6(4):e251\u2013e260. https:\/\/doi.org\/10.1016\/S2589-7500(23)00265-0. PMID: 38519153","DOI":"10.1016\/S2589-7500(23)00265-0"},{"issue":"5","key":"326_CR18","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1007\/s00259-025-07673-6","volume":"53","author":"CP Spielvogel","year":"2026","unstructured":"Spielvogel CP, K\u00f6fler M, Jiang Z, Ning J, Yu J, Haberl D, Kronberger C, Poledniczek M, Schmid LM, Kersting D, Ermolaev N, Eslam RB, Auer-Grumbach M, Binder C, Duca F, Nitsche C, Kastner J, Bergler-Klein J, Kammerlander AA, Hengstenberg C, Hacker M, Calabretta R, Rettl R (2026 Apr) Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT\/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence. Eur J Nucl Med Mol Imag 53(5):3310\u20133324. https:\/\/doi.org\/10.1007\/s00259-025-07673-6. Epub 2025 Nov 29. PMID: 41317182; PMCID: PMC13013229","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"326_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00259-024-06865-w","volume":"52","author":"HSA Tingen","year":"2024","unstructured":"Tingen HSA, Groothof D, Tubben A, Bijzet J, Houwerzijl EJ, Muntinghe FLH, van der Zwaag PA, van der Meer P, Hazenberg BPC, Slart RHJA, Nienhuis HLA (2024) [99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients. Eur J Nucl Med Mol Imag 52(1):88\u201397. https:\/\/doi.org\/10.1007\/s00259-024-06865-w","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"326_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00259-023-06459-y","volume":"51","author":"HSA Tingen","year":"2024","unstructured":"Tingen HSA, Tubben A, Bijzet J, van den Berg MP, van der Meer P, Houwerzijl EJ, Muntinghe FLH, van der Zwaag PA, Glaudemans AWJM, Oerlemans MIFJ, Knackstedt C, Michels M, Hirsch A, Hazenberg BPC, Slart RHJA, Nienhuis HLA (2024 Feb) Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker? Eur J Nucl Med Mol Imag 51(3):681\u2013690. https:\/\/doi.org\/10.1007\/s00259-023-06459-y. Epub 2023 Oct 16. PMID: 37843599; PMCID: PMC10796605","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"7","key":"326_CR21","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00259-025-07092-7","volume":"52","author":"M Ungericht","year":"2025","unstructured":"Ungericht M, Schuetz T, Messner M, Puelacher C, Staggl S, Zaruba M-M, Kroiss AS, Bauer A, Poelzl G (2025) Effects of tafamidis on serial [99mTc]Tc-DPD scintigraphy in transthyretin amyloid cardiomyopathy. Eur J Nucl Med Mol Imag 52(7):2529\u20132537. https:\/\/doi.org\/10.1007\/s00259-025-07092-7","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"326_CR22","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00259-025-07079-4","volume":"52","author":"AL Yu","year":"2025","unstructured":"Yu AL, Chen YC, Tsai CH, Chao C-C, Su M-Y, Shun C-T, Hsueh H-W, Juang J-MJ, Lee M-J, Tseng P-H, Hsieh S-T, Cheng M-F, Lin Y-H (2025) Impact of tafamidis on [99mTc]Tc-pyrophosphate scintigraphy in Ala97Ser hereditary transthyretin amyloid cardiomyopathy: significant initial reduction with stable long-term effects. Eur J Nucl Med Mol Imag 52(5):1853\u20131863. https:\/\/doi.org\/10.1007\/s00259-025-07079-4","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lana.2026.101396","volume":"56","author":"E Zavaleta-Monestel","year":"2026","unstructured":"Zavaleta-Monestel E, Mora-Jim\u00e9nez J, Arguedas-Chac\u00f3n S, Salas-Segura J (2026) Bridging innovation and access: integrating cardiac amyloidosis into health system strengthening in the Americas. Lancet Reg Health - Americas 56:56. https:\/\/doi.org\/10.1016\/j.lana.2026.101396","journal-title":"Lancet Reg Health - Americas"},{"issue":"3","key":"326_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00259-024-06981-7","volume":"52","author":"M Zhao","year":"2025","unstructured":"Zhao M, Calabretta R, Binder P, Yu J, Jiang Z, Nitsche C, Bartko P, Rettl R, Wollenweber T, Mascherbauer K, Bondermann D, Hacker M, Li X (2025) Clinical significance of quantitative assessment of right ventricular amyloid burden with [99mTc]Tc-DPD SPECT\/CT in transthyretin cardiac amyloidosis. Eur J Nucl Med Mol Imag 52(3):1073\u20131082. https:\/\/doi.org\/10.1007\/s00259-024-06981-7","journal-title":"Eur J Nucl Med Mol Imag"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-026-00326-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:01:57Z","timestamp":1792360917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-026-00326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1186\/s41824-026-00326-3","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable for this short communication.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors used a large language model developed by OpenAI to improve the clarity, structure, and overall language of the manuscript. No AI tools were used for data collection, data analysis, image generation, or scientific content generation.","order":3,"name":"Ethics","label":"Declaration of AI use","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"MZZ and MMO declares no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"43"}}